Assignee
YUHAN CORP
KR·81 granted patents·23 pending applications·339 citations·filing 1989–2025
Top patents by PatentIndex Score
104 records- 0195US11492335B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Nov 8, 2022·5 cites·17 claims
- 0295US11286253B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2020·Granted Mar 29, 2022·4 cites·10 claims
- 0395US10562865B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Feb 18, 2020·11 cites·29 claims
- 0494US10899719B2Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Jan 26, 2021·8 cites·9 claims
- 0593US9593098B2Compounds and compositions for modulating EGFR mutant kinase activitiesYUHAN CORP·Filed 2015·Granted Mar 14, 2017·19 cites·20 claims
- 0692US11713308B23,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2021·Granted Aug 1, 2023·2 cites·9 claims
- 0792US11091479B2Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Aug 17, 2021·6 cites·38 claims
- 0892US10995086B2Triazolone derivatives or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted May 4, 2021·7 cites·30 claims
- 0991US11168073B23,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2019·Granted Nov 9, 2021·5 cites·32 claims
- 1091US11136364B2Dual function proteins comprising FGF21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2016·Granted Oct 5, 2021·6 cites·25 claims
- 1191US10889578B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2018·Granted Jan 12, 2021·4 cites·33 claims
- 1290USD965984SToothbrushYUHAN CORP·Filed 2020·Granted Oct 11, 2022·14 cites·1 claims
- 1388US6680053B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2001·Granted Jan 20, 2004·19 cites·3 claims
- 1487US12428401B2Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the sameYUHAN CORP·Filed 2024·Granted Sep 30, 2025·0 cites·8 claims
- 1587US5750531APyrimidine derivatives and processes for the preparation thereofYUHAN CORP·Filed 1995·Granted May 12, 1998·91 cites·13 claims
- 1685US12187714B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2023·Granted Jan 7, 2025·0 cites·3 claims
- 1785US6252076B1Process for preparation of pyrimidine derivativesYUHAN CORP·Filed 2000·Granted Jun 26, 2001·18 cites·2 claims
- 1885US2024190959A1Antigen Binding Proteins that Bind PD-L1YUHAN CORP·Filed 2024·Application pending·0 cites
- 1981US8367704B2Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compoundsYUHAN CORP·Filed 2009·Granted Feb 5, 2013·3 cites·12 claims
- 2081US2024417392A13,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 2180US12522602B2Derivatives having 2,3-dihydro-1H-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Jan 13, 2026·1 cites·28 claims
- 2280US7662832B2Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2005·Granted Feb 16, 2010·6 cites·6 claims
- 2380US7196177B2Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the sameYUHAN CORP·Filed 2006·Granted Mar 27, 2007·4 cites·5 claims
- 2479US10227330B2Diaminopyrimidine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2017·Granted Mar 12, 2019·2 cites·6 claims
- 2579US2025270269A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2024·Application pending·0 cites
- 2678US11708362B2Process for preparing aminopyrimidine derivativesYUHAN CORP·Filed 2022·Granted Jul 25, 2023·0 cites·1 claims
- 2777US7645450B2Humanized antibody specific for tumor necrosis factor-alphaYUHAN CORP·Filed 2005·Granted Jan 12, 2010·4 cites·6 claims
- 2876US11919952B2Antigen binding proteins that bind PD-L1YUHAN CORP·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 2976US6924368B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2003·Granted Aug 2, 2005·3 cites·7 claims
- 3076US2024279296A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2023·Application pending·0 cites
- 3175US12338237B2Derivatives having 1,2,3,4-tetrahydronaphthalene moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2020·Granted Jun 24, 2025·1 cites·18 claims
- 3275US2023212249A1Method for producing dual function proteins and its derivativesYUHAN CORP·Filed 2022·Application pending·0 cites
- 3374US7112664B2Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the sameYUHAN CORP·Filed 2003·Granted Sep 26, 2006·2 cites·5 claims
- 3473US11945798B2Substituted aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Apr 2, 2024·0 cites·39 claims
- 3573US6251427B1Pharmaceutical capsule compositions containing loratadine and psuedoephedrineYUHAN CORP·Filed 2000·Granted Jun 26, 2001·11 cites·3 claims
- 3673US2026035429A1Method for producing dual function proteins and its derivativesYUHAN CORP·Filed 2025·Application pending·0 cites
- 3772USRE50528ECompounds and compositions for modulating EGFR mutant kinase activitiesYUHAN CORP·Filed 2022·Granted Aug 12, 2025·0 cites·23 claims
- 3872US12258328B26-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·20 claims
- 3972US7109320B2Nucleic acid molecules encoding human tumor necrosis factor α-specific antibodiesYUHAN CORP·Filed 2004·Granted Sep 19, 2006·2 cites·10 claims
- 4072US2026098038A1Novel derivatives having 2,3-dihydro-1h-indene or 2,3-dihydrobenzofuran moiety or pharmaceutically acceptable salt thereof and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2025·Application pending·0 cites
- 4171US12258327B25-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitorsYUHAN CORP·Filed 2022·Granted Mar 25, 2025·0 cites·25 claims
- 4271US11981659B2Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the sameYUHAN CORP·Filed 2022·Granted May 14, 2024·0 cites·17 claims
- 4370US11623925B2Processes for preparing a diaminopyrimidine derivative or acid addition salt thereofYUHAN CORP·Filed 2022·Granted Apr 11, 2023·0 cites·6 claims
- 4470US5739105ACyclosporin containing composition and process for the preparation thereofYUHAN CORP·Filed 1995·Granted Apr 14, 1998·38 cites·11 claims
- 4569US11820769B2Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the sameYUHAN CORP·Filed 2021·Granted Nov 21, 2023·0 cites·26 claims
- 4669US7342027B21-phenylpiperidin-3-one derivatives and processes for the preparation thereofYUHAN CORP·Filed 2003·Granted Mar 11, 2008·6 cites·10 claims
- 4768US7541366B2Pyrrolo[3,2-c]pyridine derivatives and processes for the preparation thereofYUHAN CORP·Filed 2005·Granted Jun 2, 2009·1 cites·7 claims
- 4868US2022002367A1Long-acting fgf21 fusion proteins and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 4968US2022002368A1Dual function proteins comprising fgf21 mutant protein and pharmaceutical composition comprising sameYUHAN CORP·Filed 2021·Application pending·0 cites
- 5067USD965985SToothbrushYUHAN CORP·Filed 2020·Granted Oct 11, 2022·3 cites·1 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when YUHAN CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →